These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 21632074

  • 1. Serum adiponectin levels and tissue expression of adiponectin receptors are associated with risk, stage, and grade of colorectal cancer.
    Gialamas SP, Petridou ET, Tseleni-Balafouta S, Spyridopoulos TN, Matsoukis IL, Kondi-Pafiti A, Zografos G, Mantzoros CS.
    Metabolism; 2011 Nov; 60(11):1530-8. PubMed ID: 21632074
    [Abstract] [Full Text] [Related]

  • 2. Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies.
    Petridou ET, Mitsiades N, Gialamas S, Angelopoulos M, Skalkidou A, Dessypris N, Hsi A, Lazaris N, Polyzos A, Syrigos C, Brennan AM, Tseleni-Balafouta S, Mantzoros CS.
    Oncology; 2007 Nov; 73(3-4):261-9. PubMed ID: 18424891
    [Abstract] [Full Text] [Related]

  • 3. Adiponectin and adiponectin receptor in relation to colorectal cancer progression.
    Byeon JS, Jeong JY, Kim MJ, Lee SM, Nam WH, Myung SJ, Kim JG, Yang SK, Kim JH, Suh DJ.
    Int J Cancer; 2010 Dec 15; 127(12):2758-67. PubMed ID: 21351255
    [Abstract] [Full Text] [Related]

  • 4. Clinical significance of AGE-RAGE axis in colorectal cancer: associations with glyoxalase-I, adiponectin receptor expression and prognosis.
    Sakellariou S, Fragkou P, Levidou G, Gargalionis AN, Piperi C, Dalagiorgou G, Adamopoulos C, Saetta A, Agrogiannis G, Theohari I, Sougioultzis S, Tsioli P, Karavokyros I, Tsavaris N, Kostakis ID, Zizi-Serbetzoglou A, Vandoros GP, Patsouris E, Korkolopoulou P.
    BMC Cancer; 2016 Mar 01; 16():174. PubMed ID: 26931562
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of adiponectin levels in non-metastatic colorectal cancer.
    Ferroni P, Palmirotta R, Spila A, Martini F, Raparelli V, Fossile E, Mariotti S, Del Monte G, Buonomo O, Roselli M, Guadagni F.
    Anticancer Res; 2007 Mar 01; 27(1B):483-9. PubMed ID: 17348431
    [Abstract] [Full Text] [Related]

  • 6. Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study.
    Michalakis K, Williams CJ, Mitsiades N, Blakeman J, Balafouta-Tselenis S, Giannopoulos A, Mantzoros CS.
    Cancer Epidemiol Biomarkers Prev; 2007 Feb 01; 16(2):308-13. PubMed ID: 17301264
    [Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG, Li JW, Feng B, Beveridge M, Yue F, Lu AG, Ma JJ, Wang ML, Guo Y, Jin XL, Zheng MH.
    Eur Surg Res; 2007 Feb 01; 39(4):229-38. PubMed ID: 17446709
    [Abstract] [Full Text] [Related]

  • 8. Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors.
    Williams CJ, Mitsiades N, Sozopoulos E, Hsi A, Wolk A, Nifli AP, Tseleni-Balafouta S, Mantzoros CS.
    Endocr Relat Cancer; 2008 Mar 01; 15(1):289-99. PubMed ID: 18310295
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of serum adipokine levels in colorectal cancer patients.
    Guadagni F, Roselli M, Martini F, Spila A, Riondino S, D'Alessandro R, Del Monte G, Formica V, Laudisi A, Portarena I, Palmirotta R, Ferroni P.
    Anticancer Res; 2009 Aug 01; 29(8):3321-7. PubMed ID: 19661351
    [Abstract] [Full Text] [Related]

  • 10. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T, Nakanishi Y, Fujii G, Akishima-Fukasawa Y, Moriya Y, Kanai Y, Watanabe M, Hirohashi S.
    Oncology; 2009 Aug 01; 77(1):53-62. PubMed ID: 19556810
    [Abstract] [Full Text] [Related]

  • 11. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB.
    J Pathol; 2003 Jun 01; 200(2):183-94. PubMed ID: 12754739
    [Abstract] [Full Text] [Related]

  • 12. Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients.
    Hancke K, Grubeck D, Hauser N, Kreienberg R, Weiss JM.
    Breast Cancer Res Treat; 2010 Jan 01; 119(2):367-7. PubMed ID: 19842034
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH, Lin SR, Wu DC, Su YC, Wu JY, Cheng TL, Chi CW, Wang JY.
    Ann Surg; 2007 Dec 01; 246(6):1040-6. PubMed ID: 18043108
    [Abstract] [Full Text] [Related]

  • 14. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
    Ivanov K, Kolev N, Tonev A, Nikolova G, Krasnaliev I, Softova E, Tonchev A.
    Hepatogastroenterology; 2009 Dec 01; 56(89):94-8. PubMed ID: 19453036
    [Abstract] [Full Text] [Related]

  • 15. Association of serum adiponectin levels with breast cancer risk.
    Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, Noguchi S.
    Clin Cancer Res; 2003 Nov 15; 9(15):5699-704. PubMed ID: 14654554
    [Abstract] [Full Text] [Related]

  • 16. Prognostic impact of fascin-1 expression is more significant in advanced colorectal cancer.
    Oh SY, Kim YB, Suh KW, Paek OJ, Moon HY.
    J Surg Res; 2012 Jan 15; 172(1):102-8. PubMed ID: 20851411
    [Abstract] [Full Text] [Related]

  • 17. Adiponectin levels in patients with colorectal cancer and adenoma: a meta-analysis.
    An W, Bai Y, Deng SX, Gao J, Ben QW, Cai QC, Zhang HG, Li ZS.
    Eur J Cancer Prev; 2012 Mar 15; 21(2):126-33. PubMed ID: 21960184
    [Abstract] [Full Text] [Related]

  • 18. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study.
    Wei EK, Giovannucci E, Fuchs CS, Willett WC, Mantzoros CS.
    J Natl Cancer Inst; 2005 Nov 16; 97(22):1688-94. PubMed ID: 16288122
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of risk of liver metastasis in colorectal adenocarcinoma based on the combination of risk factors including CD10 expression: multivariate analysis of clinicopathological and immunohistochemical factors.
    Ohji Y, Yao T, Eguchi T, Yamada T, Hirahashi M, Iida M, Tsuneyoshi M.
    Oncol Rep; 2007 Mar 16; 17(3):525-30. PubMed ID: 17273728
    [Abstract] [Full Text] [Related]

  • 20. Expression of standard CD44 in human colorectal carcinoma: association with prognosis.
    Huh JW, Kim HR, Kim YJ, Lee JH, Park YS, Cho SH, Joo JK.
    Pathol Int; 2009 Apr 16; 59(4):241-6. PubMed ID: 19351367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.